Security Snapshot

Organogenesis Holdings Inc. - Common Stock, $0.01 par value (ORGO) Institutional Ownership

CUSIP: 68621F102

13F Institutional Holders and Ownership History from Q4 2018 to Q1 2026

Latest Period

Q1 2026

Institutions Reporting

117

Shares (Excl. Options)

61,633,029

Price

$2.37

Save this security page for your next review

Keep this CUSIP in your watchlists so you can revisit quarter changes from one place. If you create an account from here, we will bring you back after verification.

Latest holder snapshot 5 signals
Portfolio coverage rank
0%
Share change
-7,647,172
Value change
-$27,866,197
Number of holders
117
Issuer context Names, identifiers, and filing context for this profile. 3 identity fields
Shares outstanding
127,085,490
SEC-reported price per share
$2.62
Insider filing price
$2.62
13F Shares, Excluding Options vs Price
13F Value, Excluding Options
Total Investors

Key facts

  • ORGO - Organogenesis Holdings Inc. - Common Stock, $0.01 par value is tracked under CUSIP 68621F102.
  • 117 institutions reported positions in Q1 2026.
  • 4 significant owners is listed from Schedule 13D/13G reporting.

Change

  • Holder count moved from 147 to 117 between Q4 2025 and Q1 2026.
  • SEC-reported value moved from $359,884,065 to $146,051,135.

Research use

  • You can quickly see who holds this security, then open quarter and manager detail pages for full evidence.
  • 13F and Schedule 13D/13G sections are kept together so you can cross-check institutional and beneficial ownership context.

Evidence

Source: SEC Form 13F

Latest holder context comes from 117 institutions filings for Q1 2026.

Open SEC evidence

Security key

68621F102

Latest holder period

Q1 2026

13F holders

117

13D/G owners

4

CIK / CUSIP context first

13D/G owners

Significant owners

Large-stake holder rows connected to Schedule 13D/G evidence.

Rows
4
Security
ORGO
Filer Ownership Change % Holdings Value Net Change Nb Shares Change % Reporting Name Report Period
Ades Alan A. 18% -1.1% $66,289,913 22,319,836 0% Alan A. Ades 24 Jun 2025
NUSSDORF GLENN H 9.7% $51,688,923 12,248,560 Glenn H. Nussdorf 14 May 2025
Soleus Capital Master Fund, L.P. 7.9% -20% $42,040,854 -$10,520,474 9,985,951 -20% Soleus Capital Master Fund, L.P. 31 Dec 2025
First Light Asset Management, LLC 3.1% -50% $16,371,915 -$18,610,675 3,888,816 -53% Mathew P. Arens 31 Dec 2025

As of 31 Mar 2026, 117 institutional investors reported holding 61,633,029 shares of Organogenesis Holdings Inc. - Common Stock, $0.01 par value (ORGO). This represents 48% of the company’s total 127,085,490 outstanding shares.

13F concentration

Top 25 institutional shareholders

Largest 13F positions for this security by reported shares and value.

Top holder share
44%
Institution Ownership % Shares Held Share Change % Portfolio % Holdings Value
MORGAN STANLEY 9.1% 11,616,795 -0.19% 0% $27,531,804
Soleus Capital Management, L.P. 7.9% 10,085,951 +1% 0.97% $23,903,704
BlackRock, Inc. 3.9% 4,899,751 +2.9% 0% $11,612,411
First Light Asset Management, LLC 2.8% 3,498,533 -9.4% 0.74% $8,291,523
VANGUARD CAPITAL MANAGEMENT LLC 2.3% 2,900,816 0% 0% $6,874,934
DIMENSIONAL FUND ADVISORS LP 2.3% 2,891,006 +5.9% 0% $6,850,893
D. E. Shaw & Co., Inc. 1.8% 2,297,974 +16% 0% $5,446,198
Assenagon Asset Management S.A. 1.5% 1,967,952 -64% 0.01% $4,664,046
GEODE CAPITAL MANAGEMENT, LLC 1.4% 1,783,964 -0.17% 0% $4,229,104
DEUTSCHE BANK AG\ 1.3% 1,705,681 -48% 0% $4,042,464
ACADIAN ASSET MANAGEMENT LLC 1.2% 1,576,645 +8% 0.01% $3,732,000
STATE STREET CORP 1.2% 1,525,108 +0.38% 0% $3,614,506
VANGUARD PORTFOLIO MANAGEMENT LLC 1.1% 1,449,092 0% 0% $3,434,348
RENAISSANCE TECHNOLOGIES LLC 0.84% 1,068,538 +31% 0% $2,532,435
AQR CAPITAL MANAGEMENT LLC 0.69% 881,717 +37% 0% $2,089,669
CHARLES SCHWAB INVESTMENT MANAGEMENT INC 0.69% 879,832 +24% 0% $2,085,202
SG Americas Securities, LLC 0.62% 790,766 +40% 0% $1,874,000
NORTHERN TRUST CORP 0.44% 554,428 +3.8% 0% $1,313,995
SPHERA FUNDS MANAGEMENT LTD. 0.43% 550,000 0.22% $1,303,500
BANK OF AMERICA CORP /DE/ 0.43% 548,262 +4.3% 0% $1,299,381
CITADEL ADVISORS LLC 0.43% 544,235 -4.4% 0% $1,289,837
GOLDMAN SACHS GROUP INC 0.41% 520,350 +24% 0% $1,233,230
VANGUARD FIDUCIARY TRUST CO 0.39% 498,452 0% 0% $1,181,331
LOS ANGELES CAPITAL MANAGEMENT LLC 0.39% 491,841 +285% 0% $1,165,664
STATE OF WISCONSIN INVESTMENT BOARD 0.36% 456,367 -6.4% 0% $1,081,590

Quarter history

Institutional holders across reporting periods

Holder count, reported shares/value, and median price by quarter.

Periods
30
Latest
Q1 2026
Rows shown
1-25 of 30
Period 13F Shares, Excl. Options Value, Excl. Options Value Change Price (Median) Investors
2026 Q1 61,633,029 $146,051,135 -$27,866,197 $2.37 117
2025 Q4 69,509,561 $359,884,065 +$3,813,170 $5.18 147
2025 Q3 68,366,364 $288,461,825 -$3,867,059 $4.22 119
2025 Q2 69,383,599 $253,970,094 +$15,169,482 $3.66 113
2025 Q1 64,527,988 $278,764,897 +$10,290,470 $4.32 135
2024 Q4 62,559,435 $200,195,689 -$4,632,565 $3.20 119
2024 Q3 63,992,032 $183,024,939 +$3,073,151 $2.86 111
2024 Q2 62,887,604 $176,087,539 +$15,313,422 $2.80 114
2024 Q1 57,059,906 $162,044,497 -$4,218,961 $2.84 123
2023 Q4 58,271,447 $238,328,151 +$24,483,565 $4.09 107
2023 Q3 52,567,125 $167,155,866 +$2,434,079 $3.18 103
2023 Q2 51,683,797 $171,584,944 -$2,458,393 $3.32 111
2023 Q1 53,442,433 $113,798,804 -$5,356,219 $2.13 130
2022 Q4 56,005,330 $150,650,419 +$1,931,028 $2.69 146
2022 Q3 55,031,412 $178,300,322 -$19,442,671 $3.24 144
2022 Q2 58,051,832 $283,327,408 -$3,172,672 $4.88 140
2022 Q1 57,887,989 $440,942,195 +$10,319,977 $7.62 147
2021 Q4 55,836,563 $515,731,659 -$2,571,363 $9.24 151
2021 Q3 53,370,851 $762,477,663 +$42,467,188 $14.24 141
2021 Q2 49,939,204 $830,012,497 +$410,032,084 $16.62 140
2021 Q1 24,855,592 $453,129,001 +$68,036,540 $18.22 99
2020 Q4 21,338,757 $160,687,218 +$122,816,812 $7.53 65
2020 Q3 4,977,699 $19,103,728 +$2,285,403 $3.84 47
2020 Q2 4,380,098 $16,755,945 +$2,234,312 $3.84 47
2020 Q1 3,847,640 $12,393,195 -$1,227,774 $3.23 50
We use cookies and similar technologies to provide certain features, enhance the user experience and, if you allow them, measure engagement and deliver advertising. Analytics and marketing storage stay off until you grant consent. By clicking on "Agree and continue", you declare your consent to the use of the selected optional cookies. Manage preferences to update or revoke optional consent for future visits. For more information, see our Privacy Policy .